CI — The Cigna Group price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $295.60
- YTD price return
- +7.40%
- YTD total return
- +9.22%
- Market cap
- 77.9B
- Enterprise value
- 102.2B
- Shares outstanding
- 263.5M
- 52W low
- $255.53
- 52W high
- $318.05
- From 52W high
- -7.06%
- From 52W low
- +15.68%
- 52W range
- 64%$256–$318
- Beta
- 0.31
Volume
- Rel volume
- 1.11×
- 30D volume
- 1.7M
- 30D $ vol
- 492.2M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$924K
- Insider net 1Y
- −$66.8M
Form 4 transactions by trade date, as filed; latest on file 2026-09-03.
Fundamentals
- Sales (ttm)
- 286.3B
- Sales/share
- $1,086.58
- EPS (ttm)
- $22.66
- Book value/share
- $164.64
- Net margin
- 2.09%
- ROE
- 13.81%
- ROA
- 3.80%
- Debt / equity
- 0.66×
- Current ratio
- 0.84
Growth (CAGR, ttm) · 10Y
- Sales
- +6.81%+14.66%+10.98%+21.99%
- Net income
- -2.56%+4.03%-6.50%+12.10%
- FCF
- +160.35%+33.28%n/an/a
- Shares
- -1.36%-3.43%-4.48%+0.26%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +0.11%+8.45%-1.17%+11.89%
- Sales/share
- +8.28%+18.74%+16.19%+21.67%
- FCF/share
- +165.96%+17.81%n/an/a
- Book value/share
- +5.21%+1.78%+2.85%+11.71%
- Dividend/share
- +4.39%+8.77%+15.59%+65.57%
- Price
- +14.56%+0.77%+6.46%+8.66%
- Total return
- +17.16%+2.74%+8.46%+9.83%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 13.0×
- P/OI (ttm)
- 8.0×
- Fwd P/E
- 8.9×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 1.8×
- EV/EBITDA (fy)
- 8.1×
- EV/Sales (ttm)
- 0.4×
- Dividend yield (fwd)Div yield
- 2.11%
- Dividend yield (ttm)
- 2.09%
- Dividend/share (fwd)
- $6.24
- Buyback yield (realized, 1y)
- 1.36%
- Shareholder yield (realized, 1y)
- 3.48%
- Buyback yield (cash, ttm)
- 1.69%
- Shareholder yield (cash, ttm)
- 3.78%
Vs own 10Y history
- P/E
- 30th
- P/OI
- 13th
- P/S
- 8th
- P/B
- 43rd
- P/FCF
- 1st
Bar = where today’s multiple sits in CI’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-09#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +2.4%5Y CAGR +2.4%YoY −7.1%EPS (diluted)
5Y CAGR −0.7%10Y CAGR +10.7%YoY −21.6%Free cash flow
5Y CAGR +38.0%10Y CAGR +34.4%YoY n/mFY25: operating cash flow $9.6B, capex —
Q3 2026: operating cash flow $2.6B, capex —
Shares (diluted)
5Y −27.1%10Y +3.1%YoY −1.4%Dividend per share
5Y CAGR +172.8%10Y CAGR +65.2%YoY +3.3%About Cigna Group#
Data provided bySource: Twelve DataThe Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.
Bloomfield, CT·65,669 employees·Healthcare Plans·thecignagroup.com·As of Oct 28, 2026
Recent filings#
- Nov 5Earnings · Earnings release — EPS $7.98 vs $7.46 est. (+7.0%); revenue $73.68B (+6% y/y) 1.3%
- Jul 30Earnings · Earnings release — EPS $7.78 vs $7.58 est. (+2.6%); revenue $71.67B (+7% y/y) 3.0%
ETFs holding CI#
31 of the 193 ETFs ChartRow carries live hold CI. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 1.3% |
| VHT | Vanguard Health Care ETF | 1.0% |
| MGV | Vanguard Mega Cap Value ETF | 0.3% |
| DGRO | iShares Core Dividend Growth ETF | 0.3% |
| VYM | Vanguard High Dividend Yield ETF | 0.3% |
| VTV | Vanguard Value ETF | 0.3% |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 0.3% |
| IWD | iShares Russell 1000 Value ETF | 0.2% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +19.73% | +4.28% |
| JNJ | Johnson & Johnson | +7.91% | +2.13% |
| ABBV | AbbVie Inc. | +6.09% | +0.68% |
| MRK | Merck & Co. Inc. | +2.17% | +1.38% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.83% | +0.88% |
| NVS | Novartis AG | +13.87% | +0.70% |
| TMO | Thermo Fisher Scientific Inc. | +9.67% | +3.87% |
| AMGN | Amgen Inc. | +12.14% | +1.04% |
